Dr Eric Buenz
Dr Eric Buenz completed his Doctorate in Biomedical Science at the Mayo Clinic College of Medicine, his Master of Business Administration at the University of St. Thomas, and his Master of Agriculture at the University of the South Pacific in Samoa. He is an expert in natural products, immunology, neurology, drug discovery and business development. He has secured United States Food and Drug Administration Investigational New Drug status for novel compounds and directed the associated clinical trials for these compounds at Mayo Clinic.
Dr Buenz has authored numerous peer-reviewed manuscripts, many in high-impact journals such as The British Medical Journal and Trends in Pharmacological Sciences; his work has also been covered in the popular press in publications such as The New York Times, The Economist, Wired, and The Scientist. He has a wide range of business management experience from successfully securing venture funding for start-up organisations, to serving on non-profit boards, advising governments and running departments of multinational firms.
He has recently completed a research on the use of lead ammunition and how it contaminates the meat hunters harvest with lead fragments. These fragments can raise blood lead levels. Read more in an internal interview here(external link).
He is currently directing an international consortium examining why the kea (Nestor notabilis) are being driven to extinction. Using isotope analysis on kea blood samples we are establishing the source of the lead that is poisoning kea.